Paolo Gionchetti
#167,294
Most Influential Person Now
Researcher
Paolo Gionchetti's AcademicInfluence.com Rankings
Paolo Gionchetticomputer-science Degrees
Computer Science
#10163
World Rank
#10659
Historical Rank
Machine Learning
#4643
World Rank
#4695
Historical Rank
Artificial Intelligence
#5005
World Rank
#5070
Historical Rank
Database
#7114
World Rank
#7362
Historical Rank
Download Badge
Computer Science
Paolo Gionchetti's Degrees
- PhD Computer Science University of Milan
- Masters Computer Engineering University of Bologna
- Bachelors Information Technology University of Florence
Similar Degrees You Can Earn
Why Is Paolo Gionchetti Influential?
(Suggest an Edit or Addition)Paolo Gionchetti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. (2000) (1485)
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management (2017) (1353)
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. (2017) (1186)
- Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial (2000) (941)
- Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis (2003) (903)
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. (2010) (883)
- VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis (2005) (729)
- European evidence based consensus on the diagnosis and management of Crohn’s disease: current management (2006) (656)
- Modulation of human dendritic cell phenotype and function by probiotic bacteria (2004) (565)
- ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment. (2019) (513)
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. (2017) (505)
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. (2013) (477)
- Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. (2008) (371)
- Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. (2011) (314)
- Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. (2003) (302)
- European evidence based consensus on surgery for ulcerative colitis. (2015) (289)
- Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. (1999) (272)
- European evidence-based Consensus on the management of ulcerative colitis: Special situations. (2008) (254)
- Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial (2003) (254)
- ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment. (2019) (253)
- Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis (2006) (249)
- Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation (1998) (227)
- Antibiotic combination therapy in patients with chronic, treatment‐resistant pouchitis (1999) (226)
- Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? (1999) (225)
- Bacteria as the cause of ulcerative colitis (2001) (212)
- Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. (2016) (212)
- Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment (2001) (210)
- Four‐week open‐label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis (2002) (202)
- High-Dose Probiotics for the Treatment of Active Pouchitis (2007) (202)
- Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. (1998) (180)
- The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease. (2015) (171)
- Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. (2012) (165)
- Pregnancy outcome in inflammatory bowel disease: prospective European case‐control ECCO‐EpiCom study, 2003–2006 (2011) (157)
- Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. (1989) (152)
- The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women (2013) (150)
- Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. (1999) (143)
- The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. (2011) (139)
- Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. (2007) (134)
- Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. (1994) (134)
- Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis (1998) (130)
- Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double‐blind placebo‐controlled study (2002) (128)
- Clinical guidelines for the management of pouchitis (2009) (127)
- Probiotics in infective diarrhoea and inflammatory bowel diseases (2000) (125)
- Variants of CARD15 are Associated with an Aggressive Clinical Course of Crohn's Disease—An IG-IBD Study (2005) (121)
- Effect of probiotic strains on interleukin 8 production by HT29/19A cells (2002) (117)
- Antibiotics and probiotics in treatment of inflammatory bowel disease. (2006) (116)
- Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. (2006) (112)
- Implications of the Westernized Diet in the Onset and Progression of IBD (2019) (112)
- Local Injection of Infliximab for the Treatment of Perianal Crohn’s Disease (2005) (109)
- European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly. (2016) (107)
- Oral beclometasone dipropionate in the treatment of extensive and left‐sided active ulcerative colitis: a multicentre randomised study (2003) (106)
- ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. (2021) (102)
- Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis (2010) (96)
- Short‐term treatment with infliximab in chronic refractory pouchitis and ileitis (2008) (96)
- Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus – A GISC study (1999) (94)
- Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry. (1992) (92)
- Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. (1991) (92)
- Anti‐Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases (2003) (90)
- New insights into the brain involvement in patients with Crohn’s disease: a voxel‐based morphometry study (2013) (89)
- Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-α in ulcerative colitis (1999) (85)
- Adalimumab in active ulcerative colitis: a "real-life" observational study. (2012) (84)
- Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. (2007) (83)
- Oral versus combination mesalazine therapy in active ulcerative colitis: a double‐blind, double‐dummy, randomized multicentre study (2001) (80)
- Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. (2014) (76)
- Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. (1997) (75)
- The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases (2014) (74)
- Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. (2002) (74)
- Oral budesonide in the treatment of chronic refractory pouchitis (2007) (73)
- Probiotic Therapy in the Prevention of Pouchitis Onset: Decreased Interleukin‐1&bgr;, Interleukin‐8, and Interferon‐&ggr; Gene Expression (2005) (73)
- 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? (1988) (72)
- Brain functional changes in patients with ulcerative colitis: A functional magnetic resonance imaging study on emotional processing (2011) (66)
- Probiotics--role in inflammatory bowel disease. (2002) (64)
- Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study (2001) (64)
- Adalimumab in the Treatment of Immune-Mediated Diseases (2014) (63)
- p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis (1994) (63)
- Guideline / Consensus Paper 3 rd European Evidence-based Consensus on the Diagnosis and Management of Crohn ’ s Disease 2016 : Part 2 : Surgical Management and Special Situations (2017) (62)
- Treatment of mild to moderate ulcerative colitis and pouchitis (2002) (62)
- Management of severe ulcerative colitis with the help of high resolution ultrasonography. (1996) (58)
- Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis (1997) (58)
- Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue. (2006) (58)
- Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab (2014) (57)
- Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. (2007) (56)
- Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis (1992) (56)
- Topical Treatment of Distal Active Ulcerative Colitis With Beclomethasone Dipropionate or Mesalamine: A Single-blind Randomized Controlled Trial (2005) (55)
- Effect of probiotic strains on interleukin 8 production by HT29/19A cells. (2002) (55)
- Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. (1985) (54)
- Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitis (1994) (53)
- CT-guided percutaneous pelvic abscess drainage in Crohn’s disease (2006) (52)
- Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy (2007) (51)
- Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients (1994) (50)
- Probiotics for the treatment of postoperative complications following intestinal surgery. (2003) (50)
- Prepouch Ileitis After Ileal Pouch-anal Anastomosis: Patterns of Presentation and Risk Factors for Failure of Treatment (2018) (50)
- Maintenance treatment of chronic pouchitis: A randomised placebo-controlled, double-blind trial with A new probiotic preparation (1998) (48)
- Infliximab in the treatment of Crohn’s disease (2007) (47)
- Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis (1986) (46)
- Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches (1994) (45)
- Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn’s disease versus healthy controls (2013) (45)
- Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort. (2014) (44)
- Adult attachment and early parental experiences in patients with Crohn's disease. (2010) (43)
- Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study (2001) (41)
- Rifaximin systemic absorption in patients with ulcerative colitis (1998) (41)
- Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease. (2017) (41)
- Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. (2005) (41)
- Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). (2017) (41)
- Standard Treatment of Ulcerative Colitis (2003) (40)
- VSL3 probiotic mixture induces remission in patients with active ulcerative colitis (2003) (40)
- Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease. (2016) (39)
- Anti‐Saccharomyces cerevisiae and perinuclear anti‐neutrophil cytoplasmic antibodies in coeliac disease before and after gluten‐free diet (2005) (39)
- Long‐term efficacy of bismuth carbomer enemas in patients with treatment‐resistant chronic pouchitis (1997) (39)
- Medical treatment of severe ulcerative colitis (2003) (38)
- VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics. (2005) (38)
- Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugs (2013) (38)
- Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (2021) (37)
- Activation of signal‐transducer and activator of transcription 1 (STAT1) in pouchitis (2001) (36)
- Mucosal healing in pediatric Crohn’s disease after anti-TNF therapy: a long-term experience at a single center (2014) (36)
- Oral beclomethasone dipropionate in chronic refractory pouchitis. (2014) (35)
- Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. (2004) (35)
- Parental bonding and inflammatory bowel disease. (2010) (35)
- Local injection of adalimumab for perianal Crohn's disease: better than infliximab? (2010) (34)
- Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis (2007) (34)
- Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. (1994) (34)
- Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation (1990) (34)
- Probiotics and antibiotics in inflammatory bowel disease (2001) (33)
- A current overview of corticosteroid use in active ulcerative colitis (2019) (32)
- Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). (2019) (32)
- Prediction of relapse in patients with Crohn's disease in remission: a simplified index using laboratory tests, enhanced by clinical characteristics (1994) (32)
- Attachment and quality of life in patients with inflammatory bowel disease (2014) (32)
- Familial expression of anti- Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study (2001) (32)
- Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease (2005) (31)
- Systems Biology Approaches for Inflammatory Bowel Disease: Emphasis on Gut Microbial Metabolism (2014) (31)
- Implications of antioxidant enzymes in human gastric neoplasms. (2009) (30)
- The role of antibiotics and probiotics in pouchitis (2012) (30)
- Antimicrobials in the Management of Inflammatory Bowel Disease (2006) (30)
- Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study (2015) (29)
- Inflammatory Bowel Diseases and Spondyloarthropathies (2015) (28)
- Probiotics and barrier function in colitis (2005) (27)
- Bronchopulmonary Involvement in Ulcerative Colitis (1990) (27)
- Diagnosis and treatment of pouchitis. (2003) (27)
- The effect of transient intestinal ischemia on inflammatory parameters (2002) (27)
- COVID-19 in IBD: The experience of a single tertiary IBD center (2020) (27)
- Refractory Complex Crohn’s Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection (2019) (27)
- Probiotics in gastroenterology (2002) (26)
- Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis (1997) (26)
- Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. (2018) (24)
- Folate in gastrointestinal health and disease. (2012) (24)
- Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study (2021) (24)
- Review--antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach. (1999) (24)
- Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy (2013) (23)
- Sympathetic hyperactivity in patients with ulcerative colitis (2007) (23)
- Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis (1987) (22)
- Potential role for the common cystic fibrosis &Dgr;F508 mutation in Crohn's disease (2007) (22)
- Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis. (2013) (21)
- Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration (1994) (21)
- Ustekinumab in the management of Crohn's disease: Expert opinion. (2018) (21)
- Clinical course of microscopic colitis in a single-center cohort study. (2011) (21)
- Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study. (2006) (20)
- Comparison of scintigraphy with indium-111 leukocyte scan and ultrasonography in assessment of x-ray-demonstrated lesions of crohn's disease (1993) (20)
- Management of Inflammatory Bowel Disease: Does Rifaximin Offer Any Promise? (2005) (20)
- ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. (2021) (20)
- Parvovirus B19 Infection Localized in the Intestinal Mucosa and Associated with Severe Inflammatory Bowel Disease (2009) (20)
- Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers (1994) (19)
- The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis (2015) (19)
- Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance. (1998) (19)
- Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn’s disease (2017) (19)
- Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis (2019) (19)
- Ultrasonographic findings in Crohn's disease (2000) (18)
- The management of refractory Crohn's disease (2002) (18)
- Management of pouch dysfunction or pouchitis with an ileoanal pouch. (2004) (18)
- Systemic availability of 5‐aminosalicylic acid: comparison of delayed release and an azo‐bond preparation (1996) (18)
- CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue (2004) (17)
- Usefulness of panoramic 344°-viewing in Crohn’s disease capsule endoscopy: a proof of concept pilot study with the novel PillCam™ Crohn’s system (2020) (17)
- A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals. (1985) (17)
- 5-Aminosalicylic acid suppositories in the management of ulcerative colitis (1989) (16)
- Intracolonic Release of Nitric Oxide During Trinitrobenzene Sulfonic Acid Rat Colitis (1997) (16)
- Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis (2017) (16)
- Review article: monitoring activity in ulcerative colitis. (2002) (16)
- Monitoring activity in ulcerative colitis (2002) (16)
- Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients (2008) (16)
- Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement (2020) (15)
- Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils. (1997) (15)
- Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts. (2017) (15)
- Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon. (2013) (15)
- IBD: IBD and spondyloarthritis: joint management (2016) (14)
- Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. (2010) (14)
- Pentasa in maintenance treatment of ulcerative colitis. (1990) (13)
- Review article: aminosalicylates for distal colitis (2006) (13)
- Review article: the management of refractory Crohn's disease. (2002) (12)
- Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC). (1992) (12)
- Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease (1994) (11)
- Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease (2018) (11)
- Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? (2016) (11)
- Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission (1994) (11)
- Etiopathogenesis of infl ammatory bowel diseases (2006) (11)
- Role of conventional therapies in the era of biological treatment in Crohn's disease. (2011) (11)
- Probiotics in Inflammatory Bowel Diseases (2006) (10)
- 749 Infliximab for Prevention of Recurrence of Post-Surgical Crohn's Disease Following Ileocolonic Resection: A Randomized, Placebo-Controlled Study (2015) (10)
- Interleukin 1 in ulcerative colitis. (1991) (10)
- Macrophage and lymphocyte subpopulations in magnifying endoscopic lesions of Crohn's disease. (1988) (10)
- Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus (2019) (10)
- Review article: problematic proctitis and distal colitis. (2004) (10)
- Problematic proctitis and distal colitis (2004) (10)
- Probiotic Therapy to Prevent Pouchitis Onset (2005) (10)
- Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality. (2019) (10)
- M1085 Use of Infliximab and Adalimumab in Refractory Pouchitis (2010) (9)
- Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review. (2019) (9)
- The role of Budesonide-MMX in active ulcerative colitis (2014) (9)
- Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? (1999) (9)
- Potential role of the cannabinoid receptor CB1 in the pathogenesis of erosive and non‐erosive gastro‐oesophageal reflux disease (2010) (9)
- Colonisation of patients with ulcerative colitis (UC) in remission by a new probiotic preparation (1998) (8)
- Interleukin 1β (IL-1β) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) (2005) (8)
- Ustekinumab for treating ulcerative colitis: an expert opinion (2020) (8)
- Adult Attachment and Early Parental Experiences in Patients With Crohn's Disease (2010) (8)
- The safety of beclomethasone dipropionate in the treatment of ulcerative colitis (2018) (8)
- Polyunsaturated fatty acid pattern and fish oil treatment in inflammatory bowel disease. (1993) (8)
- Increased expression of cytokines, inducible nitric oxide synthase and matrix metalloproteinases in pouchitis: Effects of problotic treatment (2001) (8)
- Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease (2012) (7)
- An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials (2021) (7)
- 5-ASA Suppositories in Hemorrhoidal Disease (1992) (7)
- Role of rectal formulations: enemas. (1990) (7)
- Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (1990) (7)
- Strictureplasty for Crohn’s disease of the small bowel in the biologic era: long-term outcomes and risk factors for recurrence (2020) (7)
- Four cases of carcinoid tumour in Crohn’s disease: coincidence or correlation? (2013) (7)
- P393 Combination of surgical therapy and local injections of adalimumab in treatment of complex perianal Crohn's disease (2012) (7)
- 78 P High dose of probiotics is effective in the treatment of mild pouchitis. A pilot study (2002) (6)
- Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis. (2009) (6)
- Predictors of early recurrence after strictureplasty for Crohn's disease of the small bowel during the years of biologics. (2019) (6)
- The Role of Digestive Microflora and Probiotics in Inflammatory Bowel Disease (2000) (6)
- [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)]. (2015) (6)
- Influence of steroid treatment's duration in patients with active Crohn's disease (2005) (6)
- Distinct proteomic profiles characterise non‐erosive from erosive reflux disease (2011) (6)
- Transabdominal salvage surgery after pouch failure in a tertiary center: A case-matched study. (2017) (6)
- Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis (2019) (6)
- Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology. (2022) (5)
- Pouchitis: Clinical Features, Diagnosis, and Treatment (2021) (5)
- Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease (2014) (5)
- Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding (2015) (5)
- Randomized controlled trials in pouchitis. (2012) (5)
- UEG Week 2016 Poster Presentations (2016) (4)
- Influence of steroid treatment's duration in patients with active Crohn's disease (2005) (4)
- Role of probiotics in inflammatory bowel disease and intestinal infections (2001) (4)
- OP04 Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trial (2022) (4)
- Analysis of biological variables in Crohn's disease. (1996) (4)
- Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate (1990) (4)
- 5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema. (1988) (4)
- Clarithromycin treatment in patients with chronic treatment-resistant pouchitis (2001) (4)
- P712 Tofacitinib efficacy in patients with moderate to severe ulcerative colitis: Subgroup analyses of OCTAVE Induction 1 and 2 and OCTAVE Sustain by 5-aminosalicylates use (2019) (4)
- Long term remission after ileorectal anastomosis in Crohn's colitis. (2020) (3)
- Possible role of structural lipids in artificial nutrition: comparison of a linoleic acid-based with an oleic acid-based enteral formula in humans (1993) (3)
- Ileal pouchitis-related arthritis. (2002) (3)
- Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study. (2022) (3)
- Efficacy of a symbiotic preparation on functional intestinal disorders (FD) with altered bowel habit: A doublblind controlled study (2001) (3)
- Prophylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalamine (2000) (3)
- Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland (1992) (3)
- OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS (2010) (3)
- Sa1270 Early Post-Operative Endoscopic Recurrence in Crohn's Disease Patients: Data From a Large Prospective Italian Multicenter Cohort (2012) (3)
- Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370]. (2016) (3)
- 5-aminosalicylic acid for the treatment of inflammatory bowel diseases. (1985) (3)
- Macrophage subpopulations and interleukin‐1 β tissue levels in pelvic ileal pouches (1994) (3)
- P370 Prospective withdrawal trial of azathioprine (AZA) in ulcerative colitis (UC) (2014) (3)
- Cytokines and ulcerative colitis: Mucosal balance between pro and anti-inflammatory cytokines in patients with and without pouchitis (1998) (3)
- Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease (2020) (3)
- Post COVID-19 irritable bowel syndrome (2022) (3)
- P184 - Adalimumab in the treatment of active luminal and perianal Crohn's disease: a single center experience in 100 patients (2009) (3)
- TREATMENT OF ACTIVE ULCERATIVE COLITIS (1996) (3)
- Clinical management of inflammatory bowel disease (1993) (3)
- MCP-3 in inflammatory bowel disease (2000) (3)
- A New Extended Intestinal Release Formulation of Rifaximin, 400 mg Tablets, for the Treatment of Moderately Active Crohn's Disease (2011) (2)
- Probiotics, Prebiotics, and Antibiotics in IBD (2017) (2)
- Probiotic bacteria induce maturation and modulate cytokine production by human dendritic cells (2003) (2)
- [Immediate and long-term results in ileoanastomosis with reservoir in 335 consecutive cases]. (2000) (2)
- Oral beclomethasone dipropionate versus oral 5-aminosalicylic acid in the treatment of active ulcerative colitis: A randomised, 4 week, controlled study (2001) (2)
- Corrigendum to “European evidence-based consensus on the management of ulcerative colitis: Special situations” [J Crohns & Colitis 2 (2008) 63–92] (2008) (2)
- 836 Tofacitinib Efficacy in Patients With Moderate to Severe Ulcerative Colitis: Subgroup Analyses of OCTAVE Induction 1 & 2 and OCTAVE Sustain by 5-Aminosalicylates Use (2019) (2)
- [Acute inflammation of ileal reservoir after restorative ileoanal anastomosis]. (1994) (2)
- Four week treatment of metronidazole and ciprofloxacin markedly decreases refractory pouchitis and improves the quality of life (2001) (2)
- Macrophage subpopulations in pouchitis. (1992) (2)
- MEDICAL TREATMENT OF ULCERATIVE COLITIS (1996) (2)
- IBD: Sequential rescue therapy in steroid-refractory ulcerative colitis (2014) (2)
- PROBIOTIC BACTERIAL DNA INDUCES INTERLEUKIN-10 PRODUCTION BY HUMAN DENDRITIC CELLS VIA TOLL-LIKE RECEPTOR-9 (2012) (2)
- Which therapies are advisable in pouchitis? (2008) (2)
- P.08.2 the Long-Term Clinical Course of Refractory Chronic Pouchitis After Infliximab Therapy (2013) (2)
- Rescue therapy: ciclosporin or infliximab? (2013) (1)
- PP33 ADALIMUMAB DOES NOT INFLUENCE PITUITARY ADENOMA IN A CHILD WITH ACTIVE REFRACTORY CROHN'S DISEASE (2009) (1)
- Refractory pouchitis: The role of wireless capsule endoscopy (2006) (1)
- 3 P Probiotic therapy as a prophylaxis in ileo-anal anastomosis patients decreases interferon gamma, interleukin 1 beta and interleukin 8 MRNA expression (2002) (1)
- Sa1913 Adalimumab in the Treatment of Perianal Crohn's Disease: Short and Long Term Results in a Single Tertiary Center (2012) (1)
- P361 Adalimumab in the treatment of perianal Crohn's disease: Long-term results in a single tertiary center (2012) (1)
- OC.12.3 EARLY POST-OPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE IN A LARGE PROSPECTIVE ITALIAN MULTICENTER COHORT (2012) (1)
- Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology. (2023) (1)
- Medical treatment and management of severe ulcerative colitis. (2008) (1)
- Interleukin 1β (IL-1β) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) (2005) (1)
- Oral presentationProphylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalazine (2000) (1)
- P.08.17 SINGLE VS DUAL-CAMERA: A COMPARATIVE ANALYSIS OF COLON CAPSULE ENDOSCOPY TO EVALUATE THE SMALL BOWEL (2018) (1)
- W1271 Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey (2010) (1)
- Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial (2022) (1)
- Parvovirus B 19 Infection Localized in the Intestinal Mucosa and Associated with Severe Inflammatory Bowel Disease (2009) (1)
- P269 A new dedicated capsule for diagnosis and monitoring of Crohn’s disease. First patient series (2018) (1)
- P391 Risk of short-term postoperative complications in patients treated with azathioprine for Crohn's disease. A single center experience (2012) (1)
- OC.01.4 EARLY POST-OPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE IN AN ITALIAN MULTICENTRIC COHORT (2010) (1)
- Transabdominal bowel sonography modifications in patients with active Crohn's disease before and after infliximab treatment (2001) (1)
- Probiotics in GI diseases. (2010) (1)
- Comparison of oral versus combination mesalazine therapy in active ulcerative colitis: A double-blind, double-dummy, randomized, multicenteritalian study (2000) (1)
- S1214 Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort (2010) (1)
- OC.07.1 ADALIMUMAB IS EFFECTIVE IN THE TREATMENT OF ACTIVE LUMINAL CROHN'S DISEASE AND MUCOSAL HEALING: A SINGLE CENTER EXPERIENCE IN 170 PATIENTS (2010) (1)
- Macrophage andlymphocyte subpopulations inmagnifying endoscopic lesions ofCrohn's disease (1988) (1)
- P568 Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn’s disease (2021) (1)
- M1084 Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients (2010) (1)
- P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era (2018) (0)
- Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn’s Disease Adult Patients (2023) (0)
- Campieri CT-guided percutaneous pelvic abscess drainage in Crohn ’ s disease (0)
- OC.13.2 PILLCAMTM CROHN'S SYSTEM FOR CAPSULE ENDOSCOPY: RESULTS OF THE FIRST OBSERVATIONAL MULTI-CENTER STUDY (2019) (0)
- Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease. (2022) (0)
- Long-term results of cyclosporine A (CYA) treatment in severe steroid refractory ulcerative colitis (UC) (1995) (0)
- Author’s reply (2012) (0)
- P027 Treatment of Perianal Crohn's Disease with Combined Surgical and Biological Therapy (2008) (0)
- OC.06.1 PAN-ENTERIC CAPSULE ENDOSCOPY TO CHARACTERIZE CROHN’S DISEASE PHENOTYPES AND PREDICT CLINICAL OUTCOMES IN CHILDREN AND ADULTS (2022) (0)
- DOP041 Prepouch ileitis after ileal pouch anal anastomosis for ulcerative colitis: patterns of presentation and risk factors for failure of treatment. (2017) (0)
- A case of jejunal adenocarcinoma missed at cross-sectional techniques and diagnosed by capsule endoscopy. (2022) (0)
- Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach (2018) (0)
- P377 Long-term outcome after infliximab treatment for distal refractory ulcerative colitis. A single tertiary center experience (2012) (0)
- Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis (2021) (0)
- PANENTERIC CAPSULE ENDOSCOPY TO CHARACTERIZE CROHN’S DISEASE PHENOTYPES AND PREDICT CLINICAL OUTCOMES IN CHILDREN AND ADULTS (2022) (0)
- The Role of Digestive Microè ora and Probiotics in Inè ammatory Bowel Disease (2000) (0)
- 584: VEDOLIZUMAB INTRAVENOUS IS EFFECTIVE ACROSS MULTIPLE TREATMENT TARGETS IN CHRONIC POUCHITIS: RESULTS OF THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EARNEST TRIAL (2022) (0)
- Capsule Endoscopy in the Detection of Non-Small Bowel Lesions Missed by Endoscopy (2021) (0)
- Role of Biologics in Refractory Pouchitis INFLAMMATORY BOWEL DISEASE: A PRACTICAL APPROACH, SERIES #42 (2008) (0)
- P420 Long term efficacy of ustekinumab in Crohn’s disease patients after vedolizumab failure (2022) (0)
- CBP-1011. InKine Pharmaceutical Co. (2001) (0)
- S1052 Efficacy of Enemas Containing Combination of Mesalazine and Methyl-Prednisolone in Active Distal Refractory Ulcerative Colitis (2009) (0)
- Genetic analysis of inflammatory bowel disease in a large european patient population supports linkage to human chromosomes 12 and 16 (1998) (0)
- Immunomodulatory e¡ects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells (2003) (0)
- P216 Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocecal resection for Crohn’s disease: a retrospective analysis of 853 consecutive patients treated in a tertiary centre (2023) (0)
- Management and treatment of distal ulcerative colitis (2013) (0)
- specimen removal in laparoscopic ileocolic resection for Crohn’s disease: initial experience (2009) (0)
- Adalimumab in a patient with steroid-dependent Crohn's disease (2010) (0)
- [Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness]. (1989) (0)
- P367 Real-life long-term effectiveness and treatment persistence of vedolizumab in a single tertiary care cohort of Crohn’s disease patients (2020) (0)
- How do biological drugs meet treatment goals in anti-TNF naive patients, in patients with anti-TNF failure and in fistulizing patients? (2008) (0)
- W1698 Role of CB1 in Erosive and Non-Erosive Gastroesophageal Reflux Disease (2010) (0)
- Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages. (2023) (0)
- DOP058 Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn's disease? (2017) (0)
- S1667 A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa (2008) (0)
- Ultrasonography (US) in the follow-up of patients submitted to procto-colectomy with ileal pouchanal anastomosis (IPAA) (2000) (0)
- P.70 ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS (2010) (0)
- Title Page / Table of Contents / Foreword / Preface (2005) (0)
- Su1262 Adalimumab Treatment for Post-Operative Recurrence of Crohn's Disease. A Single Centre Experience (2013) (0)
- P.05.8 ORAL BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF CHRONIC REFRACTORY POUCHITIS (2012) (0)
- Intramucosal bacteria in ileal pouch (2000) (0)
- Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis. (1992) (0)
- IMPACT OF PILLCAM CROHN'S CAPSULE ON DIAGNOSTIC YIELD AND CLINICAL MANAGEMENT: RESULTS OF THE FIRST MULTICENTER, OBSERVATIONAL STUDY (2019) (0)
- Comparison of oral versus combination mesalazine therapy in active ulcerative colitis: A duble-blind, double-dummy, randomized, multi-center Italian study (2000) (0)
- T04.01.14 REAL-LIFE LONG-TERM EFFECTIVENESS AND TREATMENT PERSISTENCE OF VEDOLIZUMAB IN A SINGLE TERTIARY CARE COHORT OF CROHN'S DISEASE PATIENTS (2020) (0)
- Inflammatory bowel disease and probiotics (2002) (0)
- Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease. (2011) (0)
- Leucocyte apheresis for ulcerative colitis: Where do we stand? (2006) (0)
- Cell Proliferation Activity of Oesophageal Squamous Epithelium in Erd is Reduced Compared to NERD (2011) (0)
- Probiotic treatment in pouchitis induces changes in the activation of signaltransduction-factors STAT1 and NFKB P65 (2000) (0)
- MANAGEMENT OF POUCHITIS (2006) (0)
- P706 Monitoring asymptomatic patients with Crohn's disease: the role of intestinal ultrasound (2023) (0)
- P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years (2018) (0)
- P.1.23: CELL PROLIFERATION ACTIVITY OF OESOPHAGEAL SQUAMOUS EPITHELIUM IN ERD IS REDUCED COMPARED TO NERD (2011) (0)
- Letters to the Editor (0)
- DOP62 Morbidity after primary ileocecal resection for Crohn’s disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre (2020) (0)
- Contents Vol. 215, 2007 (2007) (0)
- The role of probiotics in pouchitis (2012) (0)
- P.71 ANTI-TNF THERAPY IN ELDERLY PEOPLE IN IBD: AN ITALIAN MULTICENTRE SURVEY (2010) (0)
- P155 - Efficacy of enemas containing combination of mesalazine and methyl-prednisolone in active distal refractory ulcerative colitis (2009) (0)
- The use of probiotics in inflammatory bowel disease (2000) (0)
- P616 Safety of COVID-19 vaccines in patients with IBD (2022) (0)
- OP08 Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trial (2023) (0)
- FRI0423 Frequency of Dactylitis and Enthesitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases:A Case-Control Study (2016) (0)
- Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials (1989) (0)
- Highly concentrated probiotics prevent pouchitis onset (2000) (0)
- Signaltrassduction-factor NFκB p65 is activated in patients with chronic relapsing pouchitis through probiotic therapy although healing occurs (2001) (0)
- P.17 ROLE OF CB1 IN THE EROSIVE AND NON-EROSIVE GASTRO-ESOPHAGEAL REFLUX DISEASE (2010) (0)
- P639 Percutaneous drainage vs surgery as definitive treatment for anastomotic leak after intestinal resection in patients with Crohn’s disease (2023) (0)
- Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation. (2016) (0)
- Clinical management of severe active ulcerative colitis in the TNF-a inhibitors era (2013) (0)
- P442 Strictureplasty for Crohn’s disease of the small bowel in the biological era: long-term outcomes and risk factors for site specific recurrence (2019) (0)
- P208 Impact of Pillcam Crohn's capsule on diagnostic yield and clinical management: results of the first multi-centre, observational study (2019) (0)
- Therapeutic goals in IBD (2008) (0)
- P571 Can Crohn's colits be cured by surgery? (2017) (0)
- Subject Index Vol. 215, 2007 (2007) (0)
- Management of Severe Attacks of Ulcerative Colitis with New Technologies (1990) (0)
- PTU-113 Quality of life in patients with ileoanal pouch: a survey comparing two different patient populations (2012) (0)
- Inflammatory bowel disease questionnaire is valid to assess the quality of life of patients with pouchitis (2003) (0)
- P683 Maintenance of deep remission in patients with ulcerative colitis treated with thiopurines after withdrawal of the drug: Perspective real-life experience of a single centre (2018) (0)
- CS.02.3 ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTER (2012) (0)
- Respiratory Burst in Macrophages from Normal and Inflamed Colon (1987) (0)
- Hepatic Artery Flow Change and Hepatocyte Oxygenation in Human Cirrhosis (1999) (0)
- P615 Safety of vedolizumab in the treatment of IBD in a single tertiary centre (2020) (0)
- Bacteria in pouch tissue (2000) (0)
- P375 Efficacy, safety, impact on natural history of long-term treatment with thiopurines in Crohn's disease patients. A single center experience (2012) (0)
- P.08.18 A NEW DEDICATED CAPSULE FOR DIAGNOSIS AND MONITORING OF CROHN'S DISEASE. FIRS PATIENT SERIES (2018) (0)
- Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn’s Disease (2023) (0)
- P443 Haemorrhoidal Artery Ligation – Recto-Anal Repair (HAL-RAR) with mucopexy for grade III hemorrhoids in IBD patients (2021) (0)
- P395 Re-induction regimen in Crohn's disease adalimumab failure or disease relapse after a first adalimumab course. A single centre experience (2013) (0)
- P386 Long term functional results and quality of life after restorative proctocolectomy for ulcerative colitis: A twenty years experience (2012) (0)
- AJG-21-1347 147..157 (0)
- P.01.2 ADALIMUMAB FOR THE TREATMENT OF POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE (2013) (0)
- Persistent parvovirus B19 infection in a case of inflammatory bowel disease (2006) (0)
- Probiotics, Prebiotics, and Antibiotics in Medical Management of Inflammatory Bowel Disease (2012) (0)
- T04.01.23 SAFETY OF VEDOLIZUMAB IN THE TREATMENT OF IBD IN A SINGLE TERTIARY CENTER (2020) (0)
- partici-Folate in gastrointestinal health and disease (2012) (0)
- P.11.19: Maintenance of Deep Remission in Patients with Ulcerative Colitis Treated with Thiopurines after Withdrawal of the Drug: Perspective Real-Life Experience of a Single Center (2017) (0)
- Pre‐pouch ileitis: authors' reply (2007) (0)
- P135 - Efficacy of infliximab in active refractory ulcerative colitis (2009) (0)
- News and controversy in inflammatory bowel disease treatment (2013) (0)
- P417 Long-term deep remission after adalimumab discontinuation in Crohn’s disease patients (2021) (0)
- Bactericidal/permeability increasing protein (BPI) is a major neutrophil antigen recognized by sera from p-ANCA positive ulcerative colitis (UC) patients (1997) (0)
- 79 OP Ileal pouch anal anastomosis: Pregnancy, delivery and pouch function (2002) (0)
- P.06.2 EFFICACY, SAFETY, IMPACT ON NATURAL HISTORY OF LONG-TERM TREATMENT WITH THIOPURINES IN CROHN'S DISEASE PATIENTS. A SINGLE CENTER EXPERIENCE (2012) (0)
- New endoscopic capsule vs upper gastrointestinal endoscopy in preoperative work-up of obese candidate for bariatric surgery: Relevance of a pilot study in the COVID-19 era (2022) (0)
- Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy. (2021) (0)
- DOP33 Predictors of ileo-rectal anastomosis, permanent ileostomy and recurrence of disease after total colectomy for Crohn’s Colitis: Results over 20 years (2021) (0)
- Macrophage subpopulations inlamina propria of normal andinflamed colon andterminal ileum (2011) (0)
- Treatment of distal colitis (2000) (0)
- Su1264 Re-Induction Regimen in Crohn's Disease Adalimumab Failure or Disease Relapse After a First Adalimumab Course. A Single Centre Experience (2013) (0)
- OC.11.4 RE-GAIN OF RESPONSE IN CROHN'S DISEASE ADALIMUMAB (ADA) DOSE-ESCALATING FAILURE OR EARLY RELAPSE. A SINGLE CENTRE EXPERIENCE (2013) (0)
- Infliximab treatment in patients with active crohn disease: Transabdominal bowel sonography modification before and after therapy (2001) (0)
- Sulphasalazine and new related compounds. (1988) (0)
- P380 Oral beclomethasone dipropionate in the treatment of chronic refractory pouchitis (2012) (0)
- OC.06.2 LONG-TERM OUTCOME AFTER INFLIXIMAB TREATMENT FOR DISTAL REFRACTORY ULCERATIVE COLITIS. A SINGLE TERTIARY CENTER EXPERIENCE (2012) (0)
- P.06.23: Capsule Endoscopy – Accuracy and Prognostic Value of Small Bowel Lesions in Patients with Crohn’s Disease (2017) (0)
- Vedolizumab for the Treatment of Chronic Pouchitis. (2023) (0)
- P604 Adalimumab for the treatment of post-operative recurrence of Crohn's disease. A single centre experience (2013) (0)
- OC.11.3 EARLY POST-OPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE: DATA FROM A LARGE PROSPECTIVE ITALIAN MULTICENTER COHORT (AN IG-IBD STUDY) (2013) (0)
- Capsule endoscopy in Crohn's disease surveillance: A monocentric, retrospective analysis in Italy (2022) (0)
- Medical Treatment of Ulcerative Colitis: Does Traditional Therapy Still Have a Role? (2019) (0)
- CXC and CC chemokine expression in ulcerative colitis (1998) (0)
- Progress ReportThe ItalianSocietyofGastroenterology(SIGE)andtheItalianGroupforthestudyof InflammatoryBowelDisease(IG-IBD)ClinicalPracticeGuidelines:The useoftumor necrosisfactor-alphaantagonisttherapyinInflammatoryBowelDisease (2011) (0)
- CXC and CC chemokine expression in inflamed and non-inflamed pelvic ileal pouch tissue (2000) (0)
- P199 Ileal pouch-anal anastomosis in women of childbearing age affected by ulcerative colitis: a single-centre study on the risk factors for infertility and outcomes of pregnancy over 17 years (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paolo Gionchetti?
Paolo Gionchetti is affiliated with the following schools:
